Dimensional Fund Advisors’s Palvella Therapeutics PVLA Stock Holding History
Bought
Maintained
Sold
Other funds holding PVLA
BI
LCM
OCA
ACM
SCM
Dimensional Fund Advisors's PVLA Position: Q2 2023 in Review
Dimensional Fund Advisors sold out of Palvella Therapeutics (PVLA) in Q2 2023, closing a stake of 1,240 shares — an estimated $96.8K sold.
Dimensional Fund Advisors first reported a position in PVLA in Q4 2018 and held it in 18 quarters. The position peaked at $1.65M in Q2 2019. 49 funds tracked by Wall St. Rank hold PVLA as of Q2 2023.
- Dimensional Fund Advisors reported no remaining Palvella Therapeutics position as of Q2 2023 after selling out during the quarter.
- Dimensional Fund Advisors sold 1,240 Palvella Therapeutics shares in Q2 2023, an estimated $96.8K.
- Dimensional Fund Advisors first reported a position in Palvella Therapeutics in Q4 2018 and held it in 18 quarters.
- Dimensional Fund Advisors's Palvella Therapeutics position peaked at $1.65M in Q2 2019.
- 49 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2023.
Based on Dimensional Fund Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.